Sayenza Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$760K
- Investors
-
10
Sayenza Bio General Information
Description
Operator of a biotechnology platform intended to democratize access to regenerative medicine by harnessing the body's fat to improve patient outcomes. The company offers an automated, multifunctional device that rapidly processes liposuction fat into optimized fat grafts and stem cell therapeutics, enabling surgeons and clinicians to deliver point-of-care aesthetic and regenerative treatments, improving clinical efficiency and outcomes.
Contact Information
Website
www.sayenza.comCorporate Office
- 5270 California Avenue
- Suite 100
- Irvine, CA 92617-3231
- United States
Corporate Office
- 5270 California Avenue
- Suite 100
- Irvine, CA 92617-3231
- United States
Sayenza Bio Timeline
Sayenza Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Seed Round | 04-Dec-2024 | $760K | Completed | Product Development | ||
| 10. Accelerator/Incubator | 28-May-2024 | Completed | Product Development | |||
| 9. Accelerator/Incubator | 01-Oct-2023 | Completed | Product Development | |||
| 8. Grant | 01-Jun-2023 | Completed | Clinical Trials - General | |||
| 7. Seed Round | 28-Mar-2023 | Completed | Clinical Trials - General | |||
| 6. Accelerator/Incubator | 01-Jan-2023 | Completed | Startup | |||
| 5. Accelerator/Incubator | 01-Jan-2023 | Completed | Startup | |||
| 4. Grant | 08-Apr-2022 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-Apr-2021 | $15K | $15K | Completed | Startup | |
| 2. Accelerator/Incubator | Completed | Product Development |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sayenza Bio Comparisons
Industry
Financing
Details
Sayenza Bio Competitors (8)
One of Sayenza Bio’s 8 competitors is GID BIO, a Venture Capital-Backed company based in Louisville, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GID BIO | Venture Capital-Backed | Louisville, CO | ||||
| Jointechlabs | Venture Capital-Backed | Brandon, FL | ||||
| Lipogems | Venture Capital-Backed | Milan, Italy | ||||
| Human Med | Private Equity-Backed | Schwerin, Germany | ||||
| Synova Life Sciences | Venture Capital-Backed | Pasadena, CA |
Sayenza Bio Patents
Sayenza Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4777607-A2 | Methods and systems for processing lipoaspirate | Pending | 20-Jul-2023 | ||
| WO-2025019868-A2 | Methods and systems for processing lipoaspirate | Inactive | 20-Jul-2023 | ||
| WO-2025019868-A3 | Methods and systems for processing lipoaspirate | Inactive | 20-Jul-2023 | ||
| EP-4687926-A2 | Fluidic device for washing of lipoaspirate | Pending | 28-Mar-2023 | ||
| US-20260284266-A1 | Fluidic device for washing of lipoaspirate | Pending | 28-Mar-2023 | A61L27/3691 |
Sayenza Bio Signals
Sayenza Bio Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| California Life Sciences | Accelerator/Incubator | |||
| National Science Foundation Innovation Corps Program | Accelerator/Incubator | Minority | ||
| McDermott Will & Schulte | Corporation | |||
| friends x family | Corporation | Minority | ||
| Octane (California) | Accelerator/Incubator |
Sayenza Bio FAQs
-
When was Sayenza Bio founded?
Sayenza Bio was founded in 2020.
-
Where is Sayenza Bio headquartered?
Sayenza Bio is headquartered in Irvine, CA.
-
What is the size of Sayenza Bio?
Sayenza Bio has 7 total employees.
-
What industry is Sayenza Bio in?
Sayenza Bio’s primary industry is Biotechnology.
-
Is Sayenza Bio a private or public company?
Sayenza Bio is a Private company.
-
What is Sayenza Bio’s current revenue?
The current revenue for Sayenza Bio is .
-
How much funding has Sayenza Bio raised over time?
Sayenza Bio has raised $1.16M.
-
Who are Sayenza Bio’s investors?
California Life Sciences, National Science Foundation Innovation Corps Program, McDermott Will & Schulte, friends x family, and Octane (California) are 5 of 10 investors who have invested in Sayenza Bio.
-
Who are Sayenza Bio’s competitors?
GID BIO, Jointechlabs, Lipogems, Human Med, and Synova Life Sciences are some of the 8 competitors of Sayenza Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process